UFLEX
1 call
Concalls & earnings callsUFLEX Limited
Every summarised call, newest first. Latest is Q1 FY27, held 17 Aug 2026.
Latest quarter
Q1 FY27 snapshot
Open full brief →UFlex delivered its highest EBITDA in 21 quarters, driven by overseas profitability and price realizations, and expects 35% top and bottom line growth for FY27.
| Metric | This quarter | Change | Five-quarter trend |
|---|---|---|---|
| Consolidated Revenue | ₹5,397.2 Cr | 38% Y-o-Y | |
| EBITDA | ₹919.8 Cr | 92% Y-o-Y | |
| EBITDA Margin | 17% | 480 basis points Y-o-Y | |
| Normalized EBITDA | ₹837.3 Cr | +78% growth YoY |
Latest guidance
- Expect 35% growth in top line and EBITDA for FY27 compared to FY26.
- Targets a similar growth rate for FY28 and expects continued growth into FY29.
- Egypt Aseptic plant commissioning targeted for H1 FY27.
- Aims to reduce interest costs by 1% in the next year.
- Debt-EBITDA leverage expected to improve to 3x by FY28.
- Volume expected to double by FY29 from current levels.
- Q2 will see normalization from exceptionally strong Q1 realizations, but underlying growth trajectory remains.
Said on the Q1 FY27 call.
Filed results
Reported quarterly history
From filed quarterly results. YoY and QoQ compare each metric on the same accounting basis.
| Quarter | Revenue | Net profit (PAT) | Basic EPS |
|---|---|---|---|
| Q3 FY25 | ₹3,734.68 Cr+12.8% YoY-2.6% QoQ | ₹136.82 CrTurned profitable YoYTurned profitable QoQ | ₹18.95Turned positive YoYTurned positive QoQ |
| Q2 FY25 | ₹3,833.38 Cr+13.8% YoY+4.9% QoQ | ₹-64.62 CrTurned loss-making YoYLoss narrowed QoQ | ₹-8.95Turned negative YoYLoss/share narrowed QoQ |
| Q1 FY25 | ₹3,653.75 Cr+12.1% YoY+6.6% QoQ | ₹-98.45 CrLoss narrowed YoYLoss narrowed QoQ | ₹-13.63Loss/share narrowed YoYLoss/share narrowed QoQ |
| Q4 FY24 | ₹3,426.46 Cr+1.4% YoY+3.5% QoQ | ₹-270.90 CrTurned loss-making YoYLoss widened QoQ | ₹-37.52Turned negative YoYLoss/share widened QoQ |
| Q3 FY24 | ₹3,309.47 Cr-5% YoY-1.8% QoQ | ₹-67.22 CrLoss narrowed YoYTurned loss-making QoQ | ₹-9.31Loss/share narrowed YoYTurned negative QoQ |
Call history
- Q1 FY27Positive tone
UFlex delivered its highest EBITDA in 21 quarters, driven by overseas profitability and price realizations, and expects 35% top and bottom line growth for FY27.
- Consolidated Revenue
- ₹5,397.2 Cr38% Y-o-Y
- EBITDA
- ₹919.8 Cr92% Y-o-Y